Genetic etiology of coronary artery disease considering NOS 3 gene variant rs1799983

Vascular

Volumn 23, Issue 3, 2015, Pages 270-276

  Nawaz, Syed Kashif ^a   Rani, Asima ^a   Yousaf, Memoona ^a   Noreen, Aasma ^a   Arshad, Muhammad ^a  

^a UNIVERSITY OF SARGODHA   (Pakistan)

Author keywords

Coronary artery disease; nitric oxide synthase 3; Pakistan; rs1799983; single nucleotide polymorphism; smoking

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA; NOS3 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA SEQUENCE; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAKISTAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; PAKISTAN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84930164686     PISSN: 17085381     EISSN: 1708539X     Source Type: Journal    
DOI: 10.1177/1708538114544783     Document Type: Article

References (44)

1. WHO (2011). http://www.worldlifeexpectancy.com/pakistan-coronary-heart-disease.
2. Wachira JK,Stys TP.Cardiovascular disease and bridging the diagnostic gap.South Dakota Med J South Dakota State Med Assoc. 2013;66:366-369
3. Altieri PI,Marcial JM,Banchs H, et al.Ethnicity and genetics are more important than diabetes mellitus and hypertension in producing cardiovascular events in patients with the metabolic syndrome: emphasis in the Puerto Rico population.Bol Asoc Med PR. 2013;105:56-63
4. Nawaz SK,Hasnain S.Pleiotropic effects of ACE polymorphism.Biochem Med. 2009;19:36-49
5. Ichihara S,Yamamoto K,Asano H, et al.Identification of a glutamic acid repeat polymorphism of ALMS1 as a novel genetic risk marker for early-onset myocardial infarction by genome-wide linkage analysis.Circ Cardiovasc Genet. 2013;6:569-578
6. Simon AS,Vijayakumar T.Molecular studies on coronary artery disease—a review.Indian J Clin Biochem. 2013;28:215-226
7. Qian J,Fulton D.Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium.Front Physiol. 2013;13:347-347
8. Hacişevki A,Gönenç A,Sezer S, et al.Accumulation of an endogenous inhibitor of nitric oxide synthesis and oxidative DNA damage in end-stage renal disease.Clin Lab. 2013;59:1353-1361
9. Atay AE,Akbas H,Tumer C, et al.The association of endothelial nitric oxide synthase gene G894T polymorphism and serum nitric oxide concentration with microalbuminuria in patients with gestational diabetes.Clin Nephrol. 2014;81:105-111
10. Zhou TB,Yin SS.Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease.Ren Fail. 2013;35:573-578
11. Abdel-Maksoud S,Ibrahim S,Samir F, et al.Correlation of Glu298Asp eNOS polymorphism with serum NO levels in Egyptian patients with coronary artery disease.Brit J Med Med Res. 2013;3:1678-1687
12. Leili R,Mandana H,Alireza N, et al.Analysis of endothelial nitric oxide synthase (eNOS) gene polymorphism GLU 298 ASP as a risk factor of coronary artery disease in a sample of Iranian population.Med Sci J Isl Azad Univ. 2012;22:116-121
13. Tian GX,Zeng XT,Wang XB, et al.Association between the endothelial nitric oxide synthase gene Glu298Asp polymorphism and coronary heart disease: A meta-analysis of 39 case-control studies.Mol Med Rep. 2013;7:1310-1318
14. Zhang X,Lynch AI,Davis BR, et al.Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: The GenHAT study.PLoS One. 2012;7:e34217-e34217
15. Bland JM,Altman GA.Statistics notes: The odds ratio.BMJ. 2000;320:1468-1468
16. Rai H,Fitt J,Sharma AK, et al.Lack of association between Glu298Asp polymorphism and coronary artery disease in North Indians.Mol Biol Rep. 2012;39:5995-6000
17. Strijdom H,Chamane N,Lochner A.Nitric oxide in the cardiovascular system: a simple molecule with complex actions.Cardiovasc J Afr. 2009;20:303-310
18. Matthews KA,Sowers MF,Derby CA, et al.Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women’s Health Across the Nation (SWAN).Am Heart J. 2005;149:1066-1073
19. Barua RS,Ambrose JA.Mechanisms of coronary thrombosis in cigarette smoke exposure.Arterioscler Thromb Vasc Biol. 2013;33:1460-1467
20. Yathish TR,Manjula C,Rinivas R, et al.A study on the association of coronary artery disease and smoking by a questionnaire method.J Clin Diagn Res. 2011;5:264-268
21. Salimi S,Firoozrai M,Zand H, et al.Endothelial nitric oxide synthase gene Glu298Asp polymorphism in patients with coronary artery disease.Ann Saudi Med. 2010;30:33-37
22. Abdel-Aziz TA,Mohamed RH.Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease.Mol Biol Rep. 2013;40:3065-3071
23. Tripathi R,Arya V,Singh PK, et al.Sequence variation in eNOS (Glu298Asp) gene and its impact on coronary artery disease: North Indian Study.Ann Biol Res. 2010;1:152-157
24. Kannel WB,McGee DL.Diabetes and cardiovascular disease.The Framingham study. JAMA. 1979;241:2035-2038
25. Moss AJ.Pathophysiologic factors influencing prognosis after myocardial infarction.J Cardiovasc Pharmacol. 1991;2:S83-S86
26. Haffner SM,Lehto S,Rönnemaa T, et al.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.N Engl J Med. 1998;339:229-234
27. Cam SF,Sekuri C,Tengiz I, et al.The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population.Thromb Res. 2005;116:287-292
28. Cai H,Wilcken DE,Wang XL.The Glu298Asp (894GT) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease.J Mol Med. 1999;77:511-514
29. Escobar E.Hypertension and coronary heart disease.J Hum Hypertension. 2002;16:S61-S63
30. Yoshimura M,Yasue H,Nakayama M, et al.A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese.Hum Genet. 1998;103:65-69
31. Alkharfy KM,Al-Daghri NM,Al-Attas OS, et al.Endothelial nitric oxide synthase gene polymorphisms (894G > T and –786T > C) and risk of coronary artery disease in a Saudi population.Arch Med Res. 2010;41:134-141
32. Gardemann A,Lohre J,Cayci S, et al.The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile.Atherosclerosis. 2002;160:167-175
33. Colombo MG,Andreassi MG,Paradossi U, et al.Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298–>Asp polymorphism) to the presence, extent, and severity of coronary artery disease.Heart. 2002;87:525-528
34. Hingorani AD,Liang CF,Fatibene J, et al.A common variant of the endothelial nitric oxide synthase (Glu298–>Asp) is a major risk factor for coronary artery disease in the UK.Circulation. 1999;100:1515-1520
35. Marsden PA,Heng HH,Scherer SW, et al.Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene.J Biol Chem. 1993;268:17478-17488
36. Angeline T,Isabel W,Tsongalis GJ.Endothelial nitric oxide gene polymorphisms, nitric oxide production and coronary artery disease risk in a South Indian population.Exp Mol Pathol. 2010;89:205-208
37. Alp E,Menevse S,Tulmac M, et al.Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population.DNA Cell Biol. 2001;28:343-350
38. Guldiken B,Tammam Sipahi T,Sibel Guldiken S, et al.Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke.Mol Biol Rep. 2009;36:1539-1543
39. Bhanushali AA,Das BR.Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians.J Commun Genet. 2010;1:55-62
40. Wang CL,Hsu LA,Ko YL, et al.Lack of association between the Glu298asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese.J Formos Med Assoc. 2001;100:736-740
41. Jaramillo PC,Muñoz MA,Lanas MC, et al.Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls.Clin Chim Acta. 2006;371:102-106
42. Kim KA,Kim JS,Kim MS.Predictors of coronary heart disease risk in healthy men and women.Taehan Kanho Hakhoe Chi. 2007;37:1039-1048
43. Nassar BA,Bevin LD,Johnstone DE, et al.Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease.Am Heart J. 2001;142:586-589
44. Nakhai-Pour HR.Glu298Asp endothelial nitric oxide synthase gene polymorphism and coronary artery disease in Caucasians, a meta-analysis.Iranian J Pub Health. 2005;34:27-28